Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Surgical Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: An Updated Systematic Review and Meta-Analysis.
Deafness in Australian Cattle Dogs associated to QTL on chromosome 20 in genome-wide association study analyses.
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.
Swanson, William
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
See All 22 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
Braun J, Kay J. The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2017 Mar; 16(3):289-302.
View in:
PubMed
subject areas
Antirheumatic Agents
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Drug Design
Health Services Accessibility
Humans
Rituximab
Tumor Necrosis Factor-alpha
authors with profiles
Jonathan Kay MD